ATE412891T1 - Verbessertes toxizität-screening verfahren - Google Patents
Verbessertes toxizität-screening verfahrenInfo
- Publication number
- ATE412891T1 ATE412891T1 AT00965025T AT00965025T ATE412891T1 AT E412891 T1 ATE412891 T1 AT E412891T1 AT 00965025 T AT00965025 T AT 00965025T AT 00965025 T AT00965025 T AT 00965025T AT E412891 T1 ATE412891 T1 AT E412891T1
- Authority
- AT
- Austria
- Prior art keywords
- screening procedures
- toxicity screening
- improved toxicity
- predicting
- cytotoxicity
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 231100000041 toxicology testing Toxicity 0.000 title 1
- 230000003013 cytotoxicity Effects 0.000 abstract 2
- 231100000135 cytotoxicity Toxicity 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Paper (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15620699P | 1999-09-27 | 1999-09-27 | |
US09/586,242 US6998249B1 (en) | 1999-09-27 | 2000-06-02 | Toxicity screening method |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE412891T1 true ATE412891T1 (de) | 2008-11-15 |
Family
ID=26852966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00965025T ATE412891T1 (de) | 1999-09-27 | 2000-09-14 | Verbessertes toxizität-screening verfahren |
Country Status (11)
Country | Link |
---|---|
US (1) | US6998249B1 (de) |
EP (1) | EP1218737B1 (de) |
JP (1) | JP2003510093A (de) |
KR (1) | KR20020048418A (de) |
AT (1) | ATE412891T1 (de) |
AU (1) | AU778295B2 (de) |
CA (1) | CA2383987A1 (de) |
DE (1) | DE60040677D1 (de) |
MX (1) | MXPA02003147A (de) |
NZ (1) | NZ517798A (de) |
WO (1) | WO2001023886A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7415358B2 (en) | 2001-05-22 | 2008-08-19 | Ocimum Biosolutions, Inc. | Molecular toxicology modeling |
US7447594B2 (en) | 2001-07-10 | 2008-11-04 | Ocimum Biosolutions, Inc. | Molecular cardiotoxicology modeling |
US7469185B2 (en) | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
WO2005047482A2 (en) * | 2003-11-12 | 2005-05-26 | Xiao Xu | Real time electronic cell sensing systems and applications for cell-based assays |
US8263375B2 (en) | 2002-12-20 | 2012-09-11 | Acea Biosciences | Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology |
US9612234B2 (en) | 2008-05-05 | 2017-04-04 | Acea Biosciences, Inc. | Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments |
US10551371B2 (en) | 2003-11-10 | 2020-02-04 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function |
US10539523B2 (en) | 2002-12-20 | 2020-01-21 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties |
US10215748B2 (en) | 2002-12-20 | 2019-02-26 | Acea Biosciences, Inc. | Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways |
US11346797B2 (en) | 2002-12-20 | 2022-05-31 | Agilent Technologies, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties |
WO2007042044A1 (en) | 2005-10-14 | 2007-04-19 | Unisense Fertilitech A/S | Determination of a change in a cell population |
US8512943B2 (en) * | 2005-12-09 | 2013-08-20 | The Regents Of The University Of California | Accessing the toxic potential of nanomaterials |
EP1996718B1 (de) * | 2006-03-06 | 2011-11-30 | Ceetox Inc. | Toxizitätsscreeningverfahren |
WO2008040532A1 (en) * | 2006-10-02 | 2008-04-10 | Cellartis Ab | Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells |
FR2908310B1 (fr) * | 2006-11-14 | 2009-07-10 | Phytodia | Produits agonistes de tgr5 et leurs applications |
ATE503000T1 (de) | 2007-06-29 | 2011-04-15 | Unisense Fertilitech As | Vorrichtung, system und verfahren zur beobachtung und/oder kultivierung mikroskopischer objekte |
WO2009100859A1 (en) * | 2008-02-14 | 2009-08-20 | F. Hoffmann-La Roche Ag | Prediction of bone marrow toxicity |
CA2723223C (en) | 2008-05-05 | 2017-06-06 | Acea Biosciences, Inc. | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution |
US20090305276A1 (en) * | 2008-06-04 | 2009-12-10 | Mckim James M | Method for Predicting Skin Sensitizing Activity of Compounds |
WO2010141954A1 (en) | 2009-06-06 | 2010-12-09 | Ceetox, Inc. | Method for predicting respiratory toxicity of compounds |
GB0911060D0 (en) | 2009-06-26 | 2009-08-12 | Ge Healthcare Uk Ltd | Methods for predicting the toxicity of a chemical |
US20120179381A1 (en) * | 2010-06-17 | 2012-07-12 | Mckim James M | Toxicity screening methods |
EP2574924A1 (de) * | 2011-09-28 | 2013-04-03 | Merck Patent GmbH | Verfahren zur Bestimmung des Status von Zellen |
US10852296B2 (en) * | 2011-12-27 | 2020-12-01 | BiOMICom Incorporated | Micro-sampling for cell, tissue, and micro-organism monitoring |
WO2015106066A1 (en) * | 2014-01-11 | 2015-07-16 | The J. David Gladstone Instututes | In vitro assays for inhibition of microglial activation |
ES2728119T3 (es) | 2014-01-14 | 2019-10-22 | Asedasciences Ag | Identificación de estados celulares funcionales |
SE540775C2 (en) * | 2016-03-21 | 2018-11-06 | Microfluidic device for culturing cells | |
GB201700138D0 (en) | 2017-01-05 | 2017-02-22 | Senzagen Ab | Analytical methods and arrays for use in the same |
EP3589299A4 (de) | 2017-03-03 | 2021-01-13 | ACEA Biosciences, Inc. | Verfahren und systeme zur funktionellen reifung von kardiomyozyten aus ipsc und esc |
JP7394367B2 (ja) | 2018-06-28 | 2023-12-08 | ダイキン工業株式会社 | 気体の細胞毒性評価方法 |
USD941488S1 (en) | 2020-02-07 | 2022-01-18 | Agilent Technologies, Inc. | Instrument for analyzing biological cells |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL62879A (en) | 1981-05-15 | 1985-09-29 | Chaya Moroz | Monoclonal antibodies,clones producing them,preparation of such antibodies and clones and cytotoxic and immunoassay using such antibodies |
US4532751B1 (en) | 1984-04-16 | 1998-02-03 | Mayer Oskar Foods | Automatic sheet product line |
GB9221664D0 (en) | 1992-10-15 | 1992-11-25 | Shiny Chemical Ind Co Limited | Propylene glycol monomethyl ether propionate and the process for the preparation thereof |
JPH10500685A (ja) | 1994-05-23 | 1998-01-20 | アーキュール,インコーポレーテッド | 少なくとも2つの構造多様性要素をもつアミンイミドおよびオキサゾロンをベースとした分子の系統的モジュール製造 |
US5525735A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
AU3577997A (en) | 1996-06-24 | 1998-01-14 | Irori | Solid phase tyrphostin library linked to matrices with memories |
-
2000
- 2000-06-02 US US09/586,242 patent/US6998249B1/en not_active Expired - Fee Related
- 2000-09-14 WO PCT/US2000/025264 patent/WO2001023886A1/en active IP Right Grant
- 2000-09-14 EP EP00965025A patent/EP1218737B1/de not_active Expired - Lifetime
- 2000-09-14 KR KR1020027003889A patent/KR20020048418A/ko not_active Application Discontinuation
- 2000-09-14 MX MXPA02003147A patent/MXPA02003147A/es active IP Right Grant
- 2000-09-14 JP JP2001527222A patent/JP2003510093A/ja active Pending
- 2000-09-14 NZ NZ517798A patent/NZ517798A/en unknown
- 2000-09-14 DE DE60040677T patent/DE60040677D1/de not_active Expired - Lifetime
- 2000-09-14 AU AU75816/00A patent/AU778295B2/en not_active Ceased
- 2000-09-14 AT AT00965025T patent/ATE412891T1/de not_active IP Right Cessation
- 2000-09-14 CA CA002383987A patent/CA2383987A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20020048418A (ko) | 2002-06-22 |
EP1218737A1 (de) | 2002-07-03 |
MXPA02003147A (es) | 2002-09-30 |
EP1218737B1 (de) | 2008-10-29 |
US6998249B1 (en) | 2006-02-14 |
AU7581600A (en) | 2001-04-30 |
CA2383987A1 (en) | 2001-04-05 |
NZ517798A (en) | 2004-03-26 |
WO2001023886A9 (en) | 2002-11-21 |
WO2001023886A1 (en) | 2001-04-05 |
JP2003510093A (ja) | 2003-03-18 |
DE60040677D1 (de) | 2008-12-11 |
AU778295B2 (en) | 2004-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE412891T1 (de) | Verbessertes toxizität-screening verfahren | |
MXPA02001403A (es) | Nuevos parametros clinicos para determinar la toxicidad hematologica previa a la radioinmunoterapia. | |
EP1371980A3 (de) | Analysekammer | |
ECSP045255A (es) | Cumarinas utiles como biomarcadores | |
BR9909844B1 (pt) | processo de preparação de compostos inibidores de cox-2. | |
BR9804214A (pt) | Compostos. | |
ATE379990T1 (de) | Verfahren zur darstellung von abgestorbenen zellen in-vivo | |
ATE342507T1 (de) | PHARMAKOPHORE REKOMBINATION ZUR IDENTIFIZIERUNG VON ßLEADß-VERBINDUNGEN VON KLEINMOLEKÜL- MEDIKAMENTEN | |
EA199900643A1 (ru) | Сульфамидные ингибиторы металлопротеаз | |
DK0921857T3 (da) | Flerbröndsplader med lav baggrund til fluorescensmålinger af biologiske og biokemiske pröver | |
WO2005010215A3 (en) | Methods for identifying tolerance modulatory compounds and uses therefor | |
DE69828080D1 (de) | Pyrimidinderivate als markierte bindungspartner | |
DE69939367D1 (de) | G protein-verwandte kinasemutanten in der essentiellen hypertonie | |
DE60103428D1 (de) | Identifizierung von zellen während kinetischer versuchsreihen | |
AU3745799A (en) | Assays for the detection of microtubule depolymerization inhibitors | |
MXPA04004018A (es) | Metodos de separacion por exclusion para toxicidad de compuestos de prueba. | |
EA200000628A1 (ru) | Ингибиторы металлопротеаз матрикса | |
AU2002309998A1 (en) | Electrochemical method for high-throughput screening of minute quantities of candidate compounds | |
ATE469238T1 (de) | Verwendung von fluor-nmr zum screening mit hohem durchsatz | |
DK0878606T3 (da) | Formindskelse af metalkorrosivitet af organiske syrer | |
WO2004063339A3 (en) | G-quadruplex binding assays and compounds therefor | |
EA200000522A1 (ru) | 5-htагонисты | |
EA200500878A1 (ru) | Кальцилитические соединения | |
EA200200162A1 (ru) | Способ деацилирования липодепсипептидов | |
EA200200160A1 (ru) | Аналоги псевдомицина с n-ацильной боковой цепью |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |